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Abstract: 
Each year 15 million babies are born prematurely and many suffer from respiratory failure due to 
immaturity of the lung and lack of control of breathing. Although respiratory support, especially 
mechanical ventilation, can improve their survival, it also causes severe injury to the vulnerable 
lung resulting in severe and chronic pulmonary morbidity lasting in to adulthood. Heterogeneity 
of lung aeration, resulting in areas of lung over inflation and lung collapse, plays a crucial part in 
the risk of mortality and morbidity due to respiratory failure.  This distribution of lung aeration 
cannot be detected by currently available bedside monitoring tools and imaging methods. Thus, 
an imaging technique for continuous non-invasive bedside monitoring of infants lung function is 
urgently needed. In order to address this, CRADL will use EIT technology to establish a 
monitoring tool for interventions in the paediatric population. 
Electrical impedance tomography (EIT) is a non-radiative, inexpensive technique that can 
facilitate real time monitoring of lung aeration, and recent studies have shown that it is effective 
in monitoring aeration in preterm babies. CRADL will show how EIT can provide new cost 
effective, easy to use, respiratory management tools and clinical protocols that can be 
universally adopted to reduce deaths and disability in preterm babies by delivering a tool that 
provides continuous, non-invasive, radiation free, bedside information on regional lung aeration 
and ventilation during daily clinical care of (preterm) infants and children with respiratory failure. 
CRADL will also assess the effectiveness, efficacy and safety of such a system in guiding 
respiratory management and supportive care of the most common causes of paediatric 
respiratory failure (respiratory distress syndrome, bronchiolitis and acute respiratory distress 
syndrome), with the final goal of reducing short and long term adverse effects of disease and its 
treatment in this population. 
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